ES2104491B1 - Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto. - Google Patents

Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto.

Info

Publication number
ES2104491B1
ES2104491B1 ES09300937A ES9300937A ES2104491B1 ES 2104491 B1 ES2104491 B1 ES 2104491B1 ES 09300937 A ES09300937 A ES 09300937A ES 9300937 A ES9300937 A ES 9300937A ES 2104491 B1 ES2104491 B1 ES 2104491B1
Authority
ES
Spain
Prior art keywords
conditioned
vaccines
vaccination against
blood disease
against rabbit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09300937A
Other languages
English (en)
Other versions
ES2104491A1 (es
Inventor
Edouard Dominique Francois
Gros Francois Xavier Le
Marcel Joseph Wittmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Publication of ES2104491A1 publication Critical patent/ES2104491A1/es
Application granted granted Critical
Publication of ES2104491B1 publication Critical patent/ES2104491B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D1/00—Surgical instruments for veterinary use
    • A61D1/02—Trocars or cannulas for teats; Vaccination appliances
    • A61D1/025—Vaccination appliances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/204—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically connected to external reservoirs for multiple refilling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3145—Filters incorporated in syringes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

CONJUNTO DE VACUNACION CONTRA LA ENFERMEDAD; HEMORRAGICA VIROL DEL CONE JO Y VACUNAS ACONDICIONADAS PARA SER UTIIIZADAS EN DICHO CONJUNTO. EL CONJUNTO DE VACUNACION COMPRENDE UN APARATO DE ADMINISTRACION POR CHORROS CON UNA CAMARA QUE PERMITE LA ADMINISTRACION POR LO MENOS POR TRES BOQUILLAS, EN UNA O DOS VECES, DE UNA DOSIS TOTAL DEL ORDEN DE 0,2 ML DE VACUNA, ASOCIADO A UNA FUENTE DE AL IMANTACION QUE CONTIENE, EN UN RECIPIENTE, LAS DOSIS DE DICHA VACUNA ACONDICIONADA PARA PRESENTAR UN TITULO PROTECTOR EN DICHO VOLUMEN DE DOSIS.
ES09300937A 1992-05-06 1993-05-04 Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto. Expired - Fee Related ES2104491B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205573A FR2690838B1 (fr) 1992-05-06 1992-05-06 Ensemble de vaccination contre la maladie hemorragique virale du lapin et vaccins conditionnes pour etre utilises dans cet ensemble.

Publications (2)

Publication Number Publication Date
ES2104491A1 ES2104491A1 (es) 1997-10-01
ES2104491B1 true ES2104491B1 (es) 1998-04-16

Family

ID=9429584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300937A Expired - Fee Related ES2104491B1 (es) 1992-05-06 1993-05-04 Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto.

Country Status (4)

Country Link
ES (1) ES2104491B1 (es)
FR (1) FR2690838B1 (es)
IT (1) IT1271447B (es)
PT (1) PT101263B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
US8591457B2 (en) * 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3788315A (en) * 1971-04-20 1974-01-29 S Laurens Disposable cutaneous transjector
US3933155A (en) * 1975-01-23 1976-01-20 Mizzy Inc. Pressure injector apparatus having improved trigger mechanism
US4103684A (en) * 1976-12-30 1978-08-01 Aaron Ismach Hydraulically powered hypodermic injector with adapters for reducing and increasing fluid injection force
CA1178503A (en) * 1982-05-27 1984-11-27 Health-Mor Personal Care Corporation Needleless hypodermic injector
FR2648701B1 (fr) * 1989-06-22 1995-10-20 Rhone Merieux Installation portative de vaccination aviaire

Also Published As

Publication number Publication date
FR2690838A1 (fr) 1993-11-12
FR2690838B1 (fr) 1996-07-12
PT101263A (pt) 1994-07-29
PT101263B (pt) 2000-09-29
IT1271447B (it) 1997-05-28
ITMI930827A1 (it) 1994-10-27
ES2104491A1 (es) 1997-10-01
ITMI930827A0 (it) 1993-04-27

Similar Documents

Publication Publication Date Title
ZA888461B (en) Azelastine-containing medicaments for application in the nose and/or at the eye
ES2042000T3 (es) Dispositivos de inhalacion con riesgo reducido de bloqueo.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
CR6458A (es) Composiciones de valdecoxib
ES2082288T3 (es) Composiciones terapeuticas para administracion intranasal de ketorolaco.
DK0388621T3 (da) Inhalator
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
DK0594607T3 (da) Forøgelse af nedreguleringen af autoimmune sygdomme ved oral eller enteral indgivelse af autoantigener
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
NO306377B1 (no) Doseform for avgivelse av et medikament
NL300185I1 (nl) Acellulair vaccin.
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
ES2104491B1 (es) Conjunto de vacunacion contra la enfermedad hemorragica viral del conejo y vacunas acondicionadas para ser utilizadas en dicho conjunto.
AR022250A1 (es) Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b.
CO4520283A1 (es) Agentes antivirales
CO4830457A1 (es) Preparados efervescentes
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
ES2110551T3 (es) Empleo de l-carnitina y acil l-carnitinas para tratamiento de pacientes que padecen sindromes relacionados con el sida y pacientes de hiv seropositivos asintomaticos.
ES2104490B1 (es) Conjunto de vacunacion contra la enterotoxemia del conejo y vacuna acondicionada para ser utilizada en este conjunto.
OA09672A (en) Use of il-4 to enhance immune response to infectious antigenic challenges
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971001

Kind code of ref document: A1

Effective date: 19971001

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20141120